Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HPS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPG21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAGA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESYT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP11B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM173 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS6KB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPM1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSU72 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HACD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on